Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03808610
Title Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute lymphoblastic leukemia

Therapies

Cyclophosphamide + Dexamethasone + Venetoclax + Vincristine Sulfate

Cyclophosphamide + Dexamethasone + Rituximab + Venetoclax + Vincristine Sulfate

Cytarabine + Methotrexate + Venetoclax

Cytarabine + Methotrexate + Rituximab + Venetoclax

Nelarabine + Pegaspargase

Prednisone + Venetoclax + Vincristine Sulfate

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.